Valuation check: STRM's profit margin is -59.33%, below the Technology sector average of 37.08%.
Get informed when a big investor buys or sells
+ FollowAs of Apr 2025
Trailing 12 months ending Apr 2025
The latest profit margin for STRM is -59.33% as of April 2025. That compares with -85.83% in the prior-year period — up 30.9% year over year. That is below the Technology sector average of 37.08%. Investors often review this figure alongside Streamline Health Solutions's historical trend and sector peers before judging valuation or financial health.
Over the past year, STRM's profit margin moved from -85.83% to -59.33% — a 30.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Streamline Health Solutions's valuation or profitability profile.
Against Technology companies, STRM currently prints -59.33% for profit margin, while the sector average sits near 37.08%. That is roughly 260.0% below the sector mean. Large gaps often invite a closer look at Streamline Health Solutions's growth, margins, and balance sheet.
Profit Margin shows how effectively Streamline Health Solutions converts resources into returns. At -59.33%, STRM may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -85.83% in the prior-year period — up 30.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting STRM's profit margin (-59.33%), review year-over-year change from -85.83%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.